Latest Accounting News

Finbar Group reports a resilient FY25 with a 16% rise in underlying profit and a robust $1 billion development pipeline, underpinned by strong sales and strategic focus.

Super Retail Group reported a solid 4.5% sales increase in FY25, driven by network growth and new loyalty initiatives, while navigating margin pressures and investing heavily in omni-channel capabilities.

Super Retail Group delivered record sales growth in FY25 despite margin pressures, expanded its store network, and boosted loyalty membership, while declaring a special dividend alongside its final payout.

Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.

WOTSO’s FY25 results reveal a robust 14% increase in underlying EBITDA, driven by its expanding flexible workspace portfolio now spanning 31 locations. Strategic investments and partnerships underpin a confident outlook toward $58 million revenue by FY30.

Frontier Digital Ventures has uncovered apparent misappropriation of approximately USD 430,000 within its Colombian business, Fincaraiz, prompting an ongoing investigation and operational safeguards.

Magellan Financial Group reported a 5% rise in operating profit for FY25 despite a 31% drop in statutory net profit, driven by strong growth in assets under management and booming income from strategic partnerships.

Perpetual Limited is set to record a significant $153.7 million non-cash impairment for FY25, largely driven by challenges in its J O Hambro boutique. This move underscores ongoing asset outflows but leaves liquidity intact.

Beam Communications finalizes the independent valuation of its Zoleo Inc. joint venture stake at US$13.7 million and confirms plans to return capital to shareholders.

Schaffer Corporation Limited reported a 1.5% increase in revenue to $229.7 million for FY2025, despite a 10.3% decline in net profit to $24.3 million. The company declared a fully franked final dividend of 45 cents per share, maintaining total dividends at 90 cents for the year.

Lycopodium Limited delivered robust FY25 financial results, hitting the top end of guidance with $339.6 million revenue and $42.2 million net profit. The company’s strategic SAXUM acquisition broadens its footprint in the Americas, positioning it well for growth in critical minerals and clean energy sectors.

Pharmx Technologies has reported a 13% revenue increase to $7.5 million for FY25, driven by expanded partnerships and platform innovations, despite a dip in EBITDA due to heavy investment.